Yale University
This study tests a digital mindfulness app called Calm Health among adults with chronic kidney disease (CKD). Participants will use the app for 6 weeks while wearing a wrist sensor that tracks sleep, physical activity, heart rate, and other health signals. The study will measure how acceptable and feasible the app is, and whether it may improve stress, anxiety, and quality of life. Participants will also receive health coaching and a personalized report showing how their mindfulness practice relates to their health data.
Chronic kidney disease (CKD) affects approximately 15% of U.S. adults and is associated with elevated rates of anxiety, depression, and diminished quality of life. Mindfulness-based interventions have demonstrated efficacy for psychological well-being in chronic illness populations, but scalable digital delivery models for CKD have not been adequately tested. This single-arm pilot feasibility trial evaluates Calm Health, a HIPAA-compliant digital mindfulness platform, among adults with CKD receiving nephrology care at Yale Medicine or Yale New Haven Hospital. Over 6 weeks, participants will u…
Inclusion Criteria: * Aged 18 to 80 years * Diagnosed with chronic kidney disease (CKD) for at least 6 months with at least two consecutive nephrology visits within the past year * Receiving CKD care at Yale Medicine Nephrology or Yale New Haven Hospital * Able to use a smartphone (study team will provide one if needed) * Able to read and write English Exclusion Criteria: * Current meditation or mindfulness practice meeting or exceeding 70 minutes per week over the past month * New or unstable psychopharmaceutical treatment in the past 2 months (stable maintenance therapy with no dose or me…
Mindfulness support
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.